MedTrace Logo

MINDD 3: Prediabetes and Delay Discounting

NCT03664726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2023-02-21

Study results available
· View outcomes & findings →

Summary

The proposed research will translate research on delay discounting to the prevention of Type 2 diabetes (T2D) in persons with prediabetes. In this study, the investigators will verify target engagement (DD) by examining if EFT improves DD under conditions shown to increase discounting of the future. Prediabetics will be randomized to receive EFT/ERT in a factorial design when experiencing simulated poverty/neutral conditions, respectively. The effects will be measured on DD. The investigators predict that poverty conditions will increase discounting of the future for ERT subjects, but those receiving EFT will show levels of DD similar to levels observed for participants in the wealth condition.

Conditions

Interventions

BEHAVIORAL

Episodic Future Thinking

Participants will be instructed to use their episodic future cues as they engage in different decision making tasks.

BEHAVIORAL

Episodic Recent Thinking

Participants will be instructed to use their episodic recent cues as they engage in different decision making tasks.

BEHAVIORAL

Scarcity Narrative

Participants will read a narrative to induce a scarcity mindset, in which they are asked to imagine a scenario in which they have lost their job and have no current secondary income.

BEHAVIORAL

Neutral Narrative

Participants will read a narrative in which they are asked to imagine a scenario in which they have been transferred between departmental jobs, with little change in salary/commute.

Sponsors & Collaborators

  • Virginia Polytechnic Institute and State University

    collaborator OTHER

  • Leonard Epstein

    lead OTHER

Principal Investigators

  • Leonard H Epstein · SUNY University at Buffalo

  • Warren K Bickel · Virginia Polytechnic Institute and State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-12
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664726 on ClinicalTrials.gov